rs201101913
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005634.3(SOX3):c.307C>A(p.Pro103Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 1,172,491 control chromosomes in the GnomAD database, including 44 homozygotes. There are 920 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005634.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOX3 | NM_005634.3 | c.307C>A | p.Pro103Thr | missense_variant | 1/1 | ENST00000370536.5 | NP_005625.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOX3 | ENST00000370536.5 | c.307C>A | p.Pro103Thr | missense_variant | 1/1 | NM_005634.3 | ENSP00000359567 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0151 AC: 1707AN: 112894Hom.: 17 Cov.: 24 AF XY: 0.0130 AC XY: 457AN XY: 35040
GnomAD3 exomes AF: 0.00484 AC: 577AN: 119122Hom.: 12 AF XY: 0.00387 AC XY: 113AN XY: 29174
GnomAD4 exome AF: 0.00166 AC: 1754AN: 1059554Hom.: 27 Cov.: 33 AF XY: 0.00136 AC XY: 461AN XY: 337754
GnomAD4 genome AF: 0.0151 AC: 1707AN: 112937Hom.: 17 Cov.: 24 AF XY: 0.0131 AC XY: 459AN XY: 35093
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 31, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 13, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at